Harmony Biosciences Holdings Inc’s recent filing unveils that its Former Officer JEFFREY G DIERKS acquired Company’s shares for reported $0.35 million on May 19 ’25. In the deal valued at $35.56 per share,9,844 shares were bought.
Then, JEFFREY G DIERKS bought 2,292 shares, generating $80,427 in total proceeds.
Before that, JEFFREY G DIERKS bought 5,000 shares. Harmony Biosciences Holdings Inc shares valued at $175,955 were divested by the Former Officer at a price of $35.19 per share.
A number of analysts have revised their coverage, including Deutsche Bank’s analysts, who began to cover the stock in mid February with a ‘”a Buy”‘ rating. H.C. Wainwright began covering HRMY with “Buy” recommendation on December 17, 2024.
Price Performance Review of HRMY
On Tuesday, Harmony Biosciences Holdings Inc [NASDAQ:HRMY] saw its stock fall -0.70% to $35.31. Over the last five days, the stock has gained 4.50%. Harmony Biosciences Holdings Inc shares have risen nearly 2.62% since the year began. Nevertheless, the stocks have risen 22.31% over the past one year. While a 52-week high of $41.61 was reached on 01/21/25, a 52-week low of $26.47 was recorded on 04/09/25. SMA at 50 days reached $31.91, while 200 days put it at $34.67.
Levels Of Support And Resistance For HRMY Stock
The 24-hour chart illustrates a support level at 34.66, which if violated will result in even more drops to 34.00. On the upside, there is a resistance level at 35.89. A further resistance level may holdings at 36.46. The Relative Strength Index (RSI) on the 14-day chart is 61.62, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.56, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 29.66%. Stochastics %K at 63.91% indicates the stock is a holding.
How much short interest is there in Harmony Biosciences Holdings Inc?
A steep rise in short interest was recorded in Harmony Biosciences Holdings Inc stocks on 2025-05-15, dropping by -0.7 million shares to a total of 2.55 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 3.25 million shares. There was a decline of -27.38%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on September 10, 2024 when UBS began covering the stock and recommended ‘”a Buy”‘ rating along with a $56 price target.
